News
Exclusive Bioscience Financial Markets Briefing with Goldman ...
Based on feedback from the Virginia Biotechnology Association (VaBIO) board of directors, bioscience CEO’s have a critical need for the latest industry-specific financial markets analysis to help make the right decisions during this challenging economic time. Through a generous sponsorship from ... read more ».
CEL-SCI Plans To Raise $5 Million
CEL-SCI Corporation (NYSE AMEX: CVM), a Vienna, VA late stage cancer immunotherapy company, announced that it has entered into a definitive agreement with one institutional investor to sell 12.5 million units, with each unit consisting of one of the Company’s common shares and 0.67 warrants to ... read more ».
Insmed Announces IPLEX Phase II Trial Results
Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, announced results from its exploratory U.S. Phase II clinical trial evaluating IPLEX(TM) (mecasermin rinfabate) in patients with myotonic muscular dystrophy (”MMD”). The randomized, double-blind, placebo-controlled Phase II trial ... read more ».
Sabin’s Hotez Awarded RSHTM Honorary Fellowship
Prof. Peter Hotez, MD, PhD was named today an Honorary Fellow of the Royal Society of Hygiene and Tropical Medicine (RSHTM). The award has been a tradition of RSHTM for more than 100 years and is presented to individuals who have made outstanding contributions towards the objectives of the ... read more ».
Alliance Contracted For First Of Kind Novel Autopsy Lab
Alliance Biosciences, a division of Alliance Engineering, Inc., was contracted by the Office of the Chief Medical Examiner for the State of VA to certify and commission the nation’s first newly-constructed high-containment autopsy lab. The lab was constructed to BSL3 standards to accommodate ... read more ».
Our Mission
The Virginia Biotechnology Association (VaBIO) is the statewide non-profit organization that promotes the scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Nearly 160 biotechnology, pharmaceutical and medical device companies are based in Virginia, mainly clustered around universities in Blacksburg, Charlottesville, Richmond, Norfolk and Northern Virginia. The bioscience industry accounts for more than $2.5 billion annually to the state's economy.
Events
July 9
Event: Bioscience Financial Markets Briefing with Goldman Sachs
When: 10:00-10:30 am
Where: Webinar and/or conference call.
Details: Through a generous sponsorship from Cooley Godward Kronish, LLP and in partnership with Goldman Sachs, VaBIO will host a complimentary members-only webinar. Analysts from Goldman Sachs will provide the most up-to-date financial outlook for our industry. The webinar is open to employees of VaBIO member companies in good standing.
Registration: Email invitations to register will be sent out on Tuesday, July 7. If you didn’t recieve an invitation and would like one, please click here.
